Literature DB >> 22366442

Induction of lymphangiogenesis through vascular endothelial growth factor-C/vascular endothelial growth factor receptor 3 axis and its correlation with lymph node metastasis in nasopharyngeal carcinoma.

Naohiro Wakisaka1, Kyoko Hirota, Satoru Kondo, Seiko Sawada-Kitamura, Kazuhira Endo, Shigeyuki Murono, Tomokazu Yoshizaki.   

Abstract

The contribution of the lymphatic system to tumor metastasis is being increasingly appreciated through studies of human cancers. As the biological behavior of nasopharyngeal carcinoma (NPC) depends on its nodal status, patients with advanced nodal status show a higher tendency toward a poor outcome. Here, we examined the role of lymphangiogenesis on lymphatic spread of NPC. We also evaluated the involvement of vascular endothelial growth factor (VEGF)-C/VEGF receptor 3 (VEGFR3) signaling pathway on lymphangiogenesis in NPC. Furthermore, we tested whether Epstein-Barr virus (EBV)-latent membrane protein (LMP) 1 induces VEGF-C. Forty-one patients with NPC were evaluated for expressions of VEGF-C and its receptor, VEGFR3, and LMP1 proteins and lymphatic vessel counts (LVC) highlighted by anti-podoplanin employing immunohistochemistry. The VEGF-C induction by LMP1 was then tested with Western blotting and enzyme-linked immunosorbent assay in vitro. The LVC and VEGF-C expression were significantly higher in cases with advanced regional lymph node metastasis (N2,3) than those with no or limited lymph node involvement (N0,1) (p=0.0380 and p=0.0109, respectively). In VEGF-C/VEGFR3-positive cases, the LVC were significantly increased compared with VEGF-C/VEGFR3-negative cases (p=0.0007). However, LMP1 expression did not show significant associations with LVC and VEGF-C-expression scores (p=0.1210 and p=0.1324, respectively). Induction of VEGF-C protein by LMP1 was not detected in vitro. These results suggest the involvement of the VEGF-C/VEGFR3 axis in the induction of lymphangiogenesis which results in lymphatic spread of NPC. However, EBV-LMP1 was not associated with the mechanism.
Copyright © 2012. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22366442     DOI: 10.1016/j.oraloncology.2012.02.003

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  15 in total

1.  Inhibition of angiogenesis by a novel neutralizing antibody targeting human VEGFR-3.

Authors:  Hao Chen; Xiuyun Ding; Yuan Gao; Xiaohua Jiang; Xiaolan Liu; Yong Chen; Jianen Gao; Xiaping Zhou; Zhiming Cai; Qihong Sun
Journal:  MAbs       Date:  2013-08-22       Impact factor: 5.857

2.  Clinical Roles of Interleukin-6 and STAT3 in Oral Squamous Cell Carcinoma.

Authors:  Kenichi Shinagawa; Souichi Yanamoto; Tomofumi Naruse; Akiko Kawakita; Kota Morishita; Yuki Sakamoto; Satoshi Rokutanda; Masahiro Umeda
Journal:  Pathol Oncol Res       Date:  2016-10-15       Impact factor: 3.201

3.  Associations between the expression of MTA1 and VEGF-C in esophageal squamous cell carcinoma with lymph angiogenesis and lymph node metastasis.

Authors:  Jianping Liu; Juan Xia; Yongheng Zhang; Maoyong Fu; Sheng Gong; Yulong Guo
Journal:  Oncol Lett       Date:  2017-07-07       Impact factor: 2.967

Review 4.  Lymphatic Vessel Network Structure and Physiology.

Authors:  Jerome W Breslin; Ying Yang; Joshua P Scallan; Richard S Sweat; Shaquria P Adderley; Walter L Murfee
Journal:  Compr Physiol       Date:  2018-12-13       Impact factor: 9.090

5.  Tumor-targeted chemotherapy with the nanopolymer-based drug NC-6004 for oral squamous cell carcinoma.

Authors:  Kazuhira Endo; Takayoshi Ueno; Satoru Kondo; Naohiro Wakisaka; Shigeyuki Murono; Makoto Ito; Kazunori Kataoka; Yasuki Kato; Tomokazu Yoshizaki
Journal:  Cancer Sci       Date:  2013-01-30       Impact factor: 6.716

6.  Immunohistochemical study of vascular endothelial growth factor-C/vascular endothelial growth factor receptor-3 expression in oral tongue squamous cell carcinoma: Correlation with the induction of lymphangiogenesis.

Authors:  Tomofumi Naruse; Souichi Yanamoto; Shin-Ichi Yamada; Hidenori Takahashi; Yuki Matsushita; Naomi Imayama; Hisazumi Ikeda; Takeshi Shiraishi; Shuichi Fujita; Tohru Ikeda; Izumi Asahina; Masahiro Umeda
Journal:  Oncol Lett       Date:  2015-08-04       Impact factor: 2.967

7.  The Epstein-Barr virus encoded LMP1 oncoprotein modulates cell adhesion via regulation of activin A/TGFβ and β1 integrin signalling.

Authors:  Mhairi A Morris; Christopher W Dawson; Louise Laverick; Alexandra M Davis; Joe P R Dudman; Sathuwarman Raveenthiraraj; Zeeshan Ahmad; Lee-Fah Yap; Lawrence S Young
Journal:  Sci Rep       Date:  2016-01-19       Impact factor: 4.379

Review 8.  Cyclooxygenase-2 expression is positively associated with lymph node metastasis in nasopharyngeal carcinoma.

Authors:  Gui Yang; Qiaoling Deng; Wei Fan; Zheng Zhang; Peipei Xu; Shihui Tang; Ping Wang; Jun'e Wang; Mingxia Yu
Journal:  PLoS One       Date:  2017-03-16       Impact factor: 3.240

9.  Overexpression of acylglycerol kinase is associated with poorer prognosis and lymph node metastasis in nasopharyngeal carcinoma.

Authors:  Qian Zhu; Su-Mei Cao; Huan-Xin Lin; Qi Yang; Sai-Lan Liu; Ling Guo
Journal:  Tumour Biol       Date:  2015-10-07

Review 10.  Modulation of the tumor microenvironment by Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma.

Authors:  Tomokazu Yoshizaki; Satoru Kondo; Kazuhira Endo; Yosuke Nakanishi; Mitsuharu Aga; Eiji Kobayashi; Nobuyuki Hirai; Hisashi Sugimoto; Miyako Hatano; Takayoshi Ueno; Kazuya Ishikawa; Naohiro Wakisaka
Journal:  Cancer Sci       Date:  2018-01-21       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.